ICT04-CYP

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameICT04-CYP
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell death stimulants
TargetsUpdating
Therapy Area/IndicationsUrinary Bladder NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitute of Cancer Therapeutics - University of Bradford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncanthera PLC
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A